Circulating Biomarkers of Tryptophan and the Kynurenine Pathway and Lung Cancer Risk
Open accessPublished version of a preprint
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Background: Imbalances in tryptophan metabolism have been linked to cancer-related immune escape and implicated in several cancers, including lung cancer. Methods: We conducted a nested case–control study within the European Prospective Investigation into Cancer and Nutrition (EPIC) that included 893 incident lung cancer cases and 1,748 matched controls. Circulating levels of tryptophan and six of its metabolites were measured and evaluated in relation to lung cancer risk. Results: Tryptophan (Ptrend = 2 × 10−5) and the kynurenine/tryptophan ratio (KTR; Ptrend = 4 × 10−5) were associated with lung cancer risk overall after adjusting for established risk factors. The ORs comparing the fifth and first quintiles (OR5th vs. 1st) were 0.52 [95% confidence interval (CI), 0.37–0.74] for tryptophan and 1.74 (95% CI, 1.24–2.45) for KTR. After adjusting for plasma methionine (available from previous work, which was strongly correlated with tryptophan), the associations of tryptophan (adjusted Ptrend = 0.13) and KTR (Ptrend = 0.009) were substantially attenuated. KTR was positively associated with squamous cell carcinoma, the OR5th vs. 1st being 2.83 (95% CI, 1.62–4.94, Ptrend = 3 × 10−5) that was only marginally affected by adjusting for methionine. Conclusions: This study indicates that biomarkers of tryptophan metabolism are associated with subsequent lung cancer risk. Although this result would seem consistent with the immune system having a role in lung cancer development, the overall associations were dependent on methionine, and further studies are warranted to further elucidate the importance of these metabolites in lung cancer etiology. Impact: This is the first prospective study investigating the tryptophan pathway in relation to lung cancer risk. Cancer Epidemiol Biomarkers Prev; 23(3); 461–8. ©2013 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Opitz, C. A., Litzenburger, U. M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., et al. (2011) · Nature · doi:10.1038/nature10491 · Cited by 1,898 · cited 4×
“In particular benzo[a] pyrene, a strong PAH carcinogen in the lung, is mediated by the aryl hydrocarbon receptor (AHR), and recent data fromOpitz and colleagues linkedTDOexpression toAHR activation (9, 16).”
BackgroundInfluentialRiboli, E., Hunt, K., Slimani, N., Ferrari, P., Norat, T., Fahey, M., Charrondière, U., Hémon, B., Casagrande, C., Vignat, J., et al. (2002) · Public Health Nutrition · doi:10.1079/phn2002394 · Cited by 1,866 · cited 1×
“EPIC recruitment procedures and collection of questionnaire data and blood samples have been described in detail elsewhere (19).”
MethodSelf-citationRelationship between interferon‐γ, indoleamine 2,3‐dioxygenase, and tryptophan catabolism
Taylor, M. W., & Feng, G. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.11.1907934 · Cited by 1,060
Monitoring tryptophan metabolism in chronic immune activation
Schröcksnadel, K., Wirleitner, B., Winkler, C., & Fuchs, D. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.013 · Cited by 551 · cited 1×
“an indirect measure of IDO activity (11, 13).”
BackgroundPesch, B., Kendzia, B., Gustavsson, P., Jöckel, K., Johnen, G., Pohlabeln, H., Olsson, A., Ahrens, W., Gross, I. M., Brüske, I., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27339 · Cited by 509
Self-citation
Research works printed but not linked: 37
- Jemal, 2011, Global cancer statistics, CA: Cancer J Clin, 61, 69
- Ferlay, 2010, Estimates of cancer incidence and mortality in Europe in 2008, Eur J Cancer, 46, 765, 10.1016/j.ejca.2009.12.014 · DOI · Paper page
- Sant, 2009, EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary, Eur J Cancer, 45, 931, 10.1016/j.ejca.2008.11.018 · DOI · Paper page
- Barbone, 1997, Cigarette smoking and histologic type of lung cancer in men, Chest, 112, 1474, 10.1378/chest.112.6.1474 · DOI
- Lyon, 2011, Tryptophan degradation in women with breast cancer: a pilot study, BMC Res Notes, 4, 156, 10.1186/1756-0500-4-156 · DOI
- Topalian, 2011, Cancer immunotherapy comes of age, J Clin Oncol: official journal of the American Society of Clinical Oncology, 29, 4828, 10.1200/JCO.2011.38.0899 · DOI · Paper page
- Prendergast, 2011, Cancer: Why tumours eat tryptophan, Nature, 478, 192, 10.1038/478192a · DOI
- Engin, 2010, Increased tryptophan degradation in patients with bronchus carcinoma, Eur J Cancer Care, 19, 803, 10.1111/j.1365-2354.2009.01122.x · DOI
- Le Floc'h, 2011, Tryptophan metabolism, from nutrition to potential therapeutic applications, Amino Acids, 41, 1195, 10.1007/s00726-010-0752-7 · DOI · Paper page
- Prendergast, 2008, Immune escape as a fundamental trait of cancer: focus on IDO, Oncogene, 27, 3889, 10.1038/onc.2008.35 · DOI · Paper page
- Kolodziej, 2011, Kynurenine metabolism in health and disease, Amino Acids, 41, 1173, 10.1007/s00726-010-0787-9 · DOI
- Hecht, 2003, Tobacco carcinogens, their biomarkers and tobacco-induced cancer, Nat Rev Cancer, 3, 733, 10.1038/nrc1190 · DOI · Paper page
- Karanikas, 2007, Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer, Cancer Biol Ther, 6, 1258, 10.4161/cbt.6.8.4446 · DOI
- Suzuki, 2010, Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer, Lung Cancer, 67, 361, 10.1016/j.lungcan.2009.05.001 · DOI · Paper page
- Johansson, 2010, Serum B vitamin levels and risk of lung cancer, JAMA, 303, 2377, 10.1001/jama.2010.808 · DOI · Paper page
- Ueland, 2007, Quantitative profiling of folate and one-carbon metabolism in large-scale epidemiological studies by mass spectrometry, Clin Chem Lab Med, 45, 1737, 10.1515/CCLM.2007.339 · DOI
- Midttun, 2009, Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography/tandem mass spectrometry, Rapid Commun Mass Spectrom, 23, 1371, 10.1002/rcm.4013 · DOI · Paper page
- Mandi, 2012, The kynurenine system and immunoregulation, J Neural Transm, 119, 197, 10.1007/s00702-011-0681-y · DOI · Paper page
- Schroecksnadel, 2005, Tryptophan degradation in patients with gynecological cancer correlates with immune activation, Cancer Letters, 223, 323, 10.1016/j.canlet.2004.10.033 · DOI
- Burns, 2011, Do changes in cigarette design influence the rise in adenocarcinoma of the lung, Cancer Causes & Control: CCC, 22, 13, 10.1007/s10552-010-9660-0 · DOI
- Thun, 1997, Cigarette smoking and changes in the histopathology of lung cancer, J Natl Cancer Inst, 89, 1580, 10.1093/jnci/89.21.1580 · DOI · Paper page
- Chaturvedi, 2010, C-reactive protein and risk of lung cancer, J Clin Oncol, 28, 2719, 10.1200/JCO.2009.27.0454 · DOI · Paper page
- Pine, 2011, Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer, J Natl Cancer Inst, 103, 1112, 10.1093/jnci/djr216 · DOI · Paper page
- Hustad, 2012, Kinetic modeling of storage effects on biomarkers related to B vitamin status and one-carbon metabolism, Clin Chem, 58, 402, 10.1373/clinchem.2011.174490 · DOI · Paper page
- Midttun, 2011, Low plasma vitamin B-6 status affects metabolism through the kynurenine pathway in cardiovascular patients with systemic inflammation, J Nutr, 141, 611, 10.3945/jn.110.133082 · DOI
- Darlington, 2010, On the biological importance of the 3-hydroxyanthranilic acid: anthranilic acid ratio, Int J Tryptophan Res, 3, 51, 10.4137/IJTR.S4282 · DOI · Paper page
- Frick, 2004, Increasing production of homocysteine and neopterin and degradation of tryptophan with older age, Clin Biochem, 37, 684, 10.1016/j.clinbiochem.2004.02.007 · DOI · Paper page
- Ledochowski, 1999, Association between insulin resistance, body mass and neopterin concentrations, Clin Chim Acta, 282, 115, 10.1016/S0009-8981(99)00019-4 · DOI
- Oxenkrug, 2010, Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism, Ann N Y Acad Sci, 1199, 1, 10.1111/j.1749-6632.2009.05356.x · DOI · Paper page
- Ozkan, 2012, Tryptophan degradation and neopterin levels in treated rheumatoid arthritis patients, Clin Rheumatol, 31, 29, 10.1007/s10067-011-1767-5 · DOI
- Spencer, 2010, Serum levels of the immune activation marker neopterin change with age and gender and are modified by race, BMI, and percentage of body fat, J Gerontol A Biol Sci Med Sci, 65, 858, 10.1093/gerona/glq066 · DOI
- Oxenkrug, 2011, Interferon-gamma - inducible inflammation: contribution to aging and aging-associated psychiatric disorders, Aging and Dis, 2, 474
- Oxenkrug, 2011, Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders, J Neural Transm, 118, 75, 10.1007/s00702-010-0475-7 · DOI · Paper page
- Sakakeeny, 2012, Plasma pyridoxal-5-phosphate is inversely associated with systemic markers of inflammation in a population of U.S. adults, J Nutr, 142, 1280, 10.3945/jn.111.153056 · DOI
- Pertovaara, 2006, The activity of the immunoregulatory enzyme indoleamine 2,3-dioxygenase is decreased in smokers, Clin Exp Immunol, 145, 469, 10.1111/j.1365-2249.2006.03166.x · DOI
- Stampfli, 2009, How cigarette smoke skews immune responses to promote infection, lung disease and cancer, Nat Rev Immunol, 9, 377, 10.1038/nri2530 · DOI · Paper page
- Nawashiro, 2006, L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors, Int J Cancer, 119, 484, 10.1002/ijc.21866 · DOI · Paper page
Cited by
Inflammation, vitamin B6 and related pathways
Ueland, P. M., McCann, A., Midttun, Ø., & Ulvik, A. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.08.001 · Cited by 382
Self-citationMetabolic interventions in the immune response to cancer
O’Sullivan, D., Sanin, D. E., Pearce, E. J., & Pearce, E. L. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0140-9 · Cited by 312
Early lung cancer diagnostic biomarker discovery by machine learning methods
Xie, Y., Meng, W.-Y., Li, R.-Z., Wang, Y.-W., Qian, X., Chan, C., Yu, Z.-F., Fan, X.-X., Pan, H.-D., Xie, C., et al. (2021) · Translational Oncology · doi:10.1016/j.tranon.2020.100907 · Cited by 269
Xiang, H., Ramil, C. P., Hai, J., Zhang, C., Wang, H., Watkins, A. A., Afshar, R., Georgiev, P., Sze, M. A., Song, X. S., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0507 · Cited by 256
A landscape of metabolic variation across tumor types
Reznik, E., Luna, A., Aksoy, B. A., Liu, E. M., La, K., Ostrovnaya, I., Creighton, C. J., Hakimi, A. A., & Sander, C. (2018) · Cell Systems · doi:10.1016/j.cels.2017.12.014 · Cited by 172
Metadata
- Authors
- Chuang, S.-C., Fanidi, A., Ueland, P. M., Relton, C., Midttun, Ø., Vollset, S. E., Gunter, M. J., Seckl, M. J., Travis, R. C., Wareham, N., Trichopoulou, A., Lagiou, P., Trichopoulos, D., Peeters, P. H. M., Bueno-de-Mesquita, H. B., Boeing, H., Wientzek, A., Kuehn, T., Kaaks, R., Tumino, R., Agnoli, C., Palli, D., Naccarati, A., Aicua, E. A., Sánchez, M.-J., Quirós, J. R., Chirlaque, M.-D., Agudo, A., Johansson, M., Grankvist, K., Boutron-Ruault, M.-C., Clavel-Chapelon, F., Fagherazzi, G., Weiderpass, E., Riboli, E., Brennan, P. J., Vineis, P., & Johansson, M.
- Venue
- Cancer Epidemiology, Biomarkers & Prevention
- Published
- 2014-03-01
- Volume
- 23
- Issue
- 3
- Pages
- 461-468
- ISSN
- 1055-9965 (ISSN-L)
- 1538-7755
- OpenAlex
- W2145635515
- Cited by
- 87
- References
- 5
- FWCI
- 0.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Circulating Biomarkers of Tryptophan and the Kynurenine Pathway and Lung Cancer Risk. https://app.cochat.ai/papers/10.1158/1055-9965.epi-13-0770
- The paper
- Chuang, S.-C., Fanidi, A., Ueland, P. M., Relton, C., Midttun, Ø., Vollset, S. E., Gunter, M. J., Seckl, M. J., Travis, R. C., Wareham, N., Trichopoulou, A., Lagiou, P., Trichopoulos, D., Peeters, P. H. M., Bueno-de-Mesquita, H. B., Boeing, H., Wientzek, A., Kuehn, T., Kaaks, R., . . . Johansson, M. (2014). Circulating Biomarkers of Tryptophan and the Kynurenine Pathway and Lung Cancer Risk. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-13-0770
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.